Generic name: DERMATOPHAGOIDES PTERONYSSINUS 6[arb'U], DERMATOPHAGOIDES FARINAE 6[arb'U]
Dosage form: tablet
Drug class: Allergenics
Medically reviewed by Drugs.com. Last updated on Mar 7, 2022.
For sublingual use only.
Administer the first dose of ODACTRA in a healthcare setting under the supervision of a physician with experience in the diagnosis and treatment of allergic diseases. After receiving the first dose of ODACTRA, observe the patient for at least 30 minutes to monitor for signs or symptoms of a severe systemic or a severe local allergic reaction. If the patient tolerates the first dose, the patient may take subsequent doses at home. The patient should administer ODACTRA as follows:
Take the tablet from the blister unit after carefully removing the foil with dry hands.
Place the tablet immediately under the tongue where it will dissolve within 10 seconds. Do not swallow for at least 1 minute.
Wash hands after handling the tablet.
Do not take the tablet with food or beverage.
Food or beverage should not be taken for 5 minutes after taking the tablet.
Data regarding the safety of restarting treatment after missing a dose of ODACTRA are limited. In the clinical studies, treatment interruptions for up to seven days were allowed.
Prescribe auto-injectable epinephrine to patients prescribed ODACTRA and instruct patients in the proper use of emergency self-injection of epinephrine [see Warnings and Precautions (5.2)].
Frequently asked questions
More about Odactra (house dust mite allergen extract)
- Side effects
- Drug interactions
- Drug images
- Pricing & coupons
- En español
- Drug class: allergenics
- FDA approval history
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.